PHIA 📈 Koninklijke Philips - Overview
Exchange: AS • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0000009538
PHIA: Medical Imaging, Patient Monitoring, Healthcare Software, Oral Care, Baby Care
Koninklijke Philips NV is a health technology company with a global presence, operating in key regions such as North America, the Greater China, and internationally. The company's business is structured around three main segments: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. This segmentation enables Philips to cater to a wide range of healthcare needs, from diagnosis and treatment to patient care and personal wellness.
Within its Diagnosis & Treatment Businesses segment, Philips offers a comprehensive portfolio of diagnostic imaging solutions, including magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems. The company's detector-based spectral CT solutions provide enhanced image quality and diagnostic capabilities, while its molecular and hybrid imaging solutions support nuclear medicine applications. Additionally, Philips' echography solutions are designed for diagnosis, treatment planning, and guidance in cardiology, general imaging, obstetrics/gynecology, and point-of-care applications. The company also provides integrated interventional systems and interventional diagnostic and therapeutic devices for treating coronary artery and peripheral vascular disease.
In the Connected Care Businesses segment, Philips focuses on delivering acute patient management solutions, emergency care solutions, sleep and respiratory care solutions, as well as electronic medical record and care management solutions. These offerings are designed to support healthcare professionals in providing high-quality patient care, while also enhancing the efficiency and effectiveness of healthcare systems. By leveraging its expertise in health technology, Philips aims to improve patient outcomes, reduce costs, and enhance the overall quality of care.
Philips' Personal Health Businesses segment encompasses a range of consumer-focused products and solutions, including power toothbrushes, brush heads, and interdental cleaning and teeth whitening products. The company also offers infant feeding, baby monitors, and digital parental solutions, as well as grooming and beauty products and solutions. These products are designed to support individuals in maintaining their health and wellbeing, from oral care to personal grooming and beauty.
Strategically, Philips has formed partnerships with leading healthcare organizations, such as TriHealth, Northwell, Atrium Health, Mayo Clinic, and Edith Cowan University. These collaborations enable the company to stay at the forefront of healthcare innovation, while also providing opportunities for knowledge sharing, research, and development. With a rich history dating back to 1891, Koninklijke Philips NV has evolved from a diversified electronics company to a focused health technology leader, with its name change in 2013 reflecting this transformation. Today, the company is headquartered in Amsterdam, the Netherlands, and is listed on the stock exchange with the ISIN code NL0000009538, classified as a common stock under the GICS Sub Industry: Health Care Equipment.
Additional Sources for PHIA Stock
PHIA Stock Overview
Market Cap in USD | 23,752m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception |
PHIA Stock Ratings
Growth 5y | -25.6% |
Fundamental | -16.7% |
Dividend | 40.8% |
Rel. Strength Industry | 3121 |
Analysts | - |
Fair Price Momentum | 23.34 EUR |
Fair Price DCF | 44.23 EUR |
PHIA Dividends
Dividend Yield 12m | 3.45% |
Yield on Cost 5y | 2.47% |
Annual Growth 5y | 0.00% |
Payout Consistency | 79.9% |
PHIA Growth Ratios
Growth Correlation 3m | -67.2% |
Growth Correlation 12m | 71% |
Growth Correlation 5y | -60.1% |
CAGR 5y | -6.36% |
CAGR/Mean DD 5y | -0.17 |
Sharpe Ratio 12m | 0.54 |
Alpha | 1.02 |
Beta | 0.68 |
Volatility | 32.70% |
Current Volume | 1083k |
Average Volume 20d | 1284.9k |
As of January 07, 2025, the stock is trading at EUR 24.63 with a total of 1,083,038 shares traded.
Over the past week, the price has changed by +1.07%, over one month by -0.77%, over three months by -15.65% and over the past year by +20.14%.
Neither. Based on ValueRay Fundamental Analyses, Koninklijke Philips is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -16.72 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHIA as of January 2025 is 23.34. This means that PHIA is currently overvalued and has a potential downside of -5.24%.
Koninklijke Philips has no consensus analysts rating.
According to ValueRays Forecast Model, PHIA Koninklijke Philips will be worth about 25.4 in January 2026. The stock is currently trading at 24.63. This means that the stock has a potential upside of +3.09%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 28.8 | 17.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 25.4 | 3.1% |